Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional paid-in capital	Accumulated deficit	Accumulated Other Comprehensive Loss	Total
Balance at the beginning at Dec. 31, 2022	$ 18	$ 577,603	$ (19,090)	$ (3,159)	$ 555,372
Balance at the beginning (in shares) at Dec. 31, 2022	176,007,184
Changes in stockholder's equity
Net Income (Loss)			(65,549)		(65,549)
Withholding of employee taxes related to stock-based compensation		(112)			(112)
Shares of common stock issued under ESPP		434			434
Shares of common stock issued under ESPP (in shares)	287,224
Shares of common stock issued for vested RSUs (in Shares)	226,201
Stock options exercised		220			220
Stock options exercised (in shares)	2,490,275
Unrealized gain on available-for-sale securities				2,600	2,600
Stock-based compensation expense		10,370			10,370
Balance at the end at Dec. 31, 2023	$ 18	588,515	(84,639)	(559)	503,335
Balance at the end (in shares) at Dec. 31, 2023	179,010,884
Changes in stockholder's equity
Net Income (Loss)			(96,520)		(96,520)
Withholding of employee taxes related to stock-based compensation		(615)			(615)
Shares of common stock issued under ESPP		412			412
Shares of common stock issued under ESPP (in shares)	387,664
Shares of common stock issued for vested RSUs (in Shares)	1,229,645
Shares of common stock issued to non-employees (in shares)	298,508
Stock options exercised	$ 1	272			$ 273
Stock options exercised (in shares)	5,141,728				5,141,728
Repurchase and retirement of shares of common stock	$ (1)	(9,162)			$ (9,163)
Repurchase and retirement of shares of common stock (in shares)	(5,704,401)				(5,704,401)
Remeasurement of mezzanine equity			(12)		$ (12)
Unrealized gain on available-for-sale securities				598	598
Stock-based compensation expense		11,972			11,972
Balance at the end at Dec. 31, 2024					34
Balance at the end at Dec. 31, 2024	$ 18	$ 591,394	$ (181,171)	$ 39	$ 410,280
Balance at the end (in shares) at Dec. 31, 2024	180,364,028